Abstract
In spite of the knowledge how to assess global CV risk and how to reduce it in primary and secondary AVN prevention, the implementation of those promotions are not succsessful in our country similarly as in the whole Europ (see results of EUROASPIRE I-IV). The up to date aims of preventive cardiology are: 1.
Life style habits modification with help of professionals, 2. To achieve recommended levels of CVD risk factors according to the global CV risk using improved phamacotherapy, 3.
To identify and influence residual vascular risk, esp. treatment of AD.